185 related articles for article (PubMed ID: 36921547)
1. The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways.
Abdelmaksoud NM; El-Mahdy HA; Ismail A; Elsakka EGE; El-Husseiny AA; Khidr EG; Ali EM; Rashed MH; El-Demerdash FE; Doghish AS
Pathol Res Pract; 2023 Apr; 244():154411. PubMed ID: 36921547
[TBL] [Abstract][Full Text] [Related]
2. A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance.
Doghish AS; Hegazy M; Ismail A; El-Mahdy HA; Elsakka EGE; Elkhawaga SY; Elkady MA; Yehia AM; Abdelmaksoud NM; Mokhtar MM
Pathol Res Pract; 2023 May; 245():154442. PubMed ID: 37031532
[TBL] [Abstract][Full Text] [Related]
3. Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review.
Ismail A; El-Mahdy HA; Abulsoud AI; Sallam AM; Eldeib MG; Elsakka EGE; Zaki MB; Doghish AS
Int J Biol Macromol; 2023 Jan; 224():1541-1565. PubMed ID: 36328268
[TBL] [Abstract][Full Text] [Related]
4. Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis.
Wu AY; Hu Y; Cang W; Li D; Wang WJ; Tian Q; Gu LY; Zhang N; Ji F; Qiu LH
Exp Cell Res; 2019 Sep; 382(2):111468. PubMed ID: 31201812
[TBL] [Abstract][Full Text] [Related]
5. Role of miRNAs in endometrial cancer.
Li S; Zhang J; Wan X
Histol Histopathol; 2015 May; 30(5):539-48. PubMed ID: 25448606
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-381 inhibits cell proliferation and invasion in endometrial carcinoma by targeting the IGF-1R.
Tu C; Wang F; Wan J
Mol Med Rep; 2018 Mar; 17(3):4090-4098. PubMed ID: 29257334
[TBL] [Abstract][Full Text] [Related]
7. Analysis of microRNA regulating cell cycle-related tumor suppressor genes in endometrial cancer patients.
Witek Ł; Janikowski T; Gabriel I; Bodzek P; Olejek A
Hum Cell; 2021 Mar; 34(2):564-569. PubMed ID: 33123872
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor microRNAs in lung cancer: An insight to signaling pathways and drug resistance.
Asghariazar V; Sakhinia E; Mansoori B; Mohammadi A; Baradaran B
J Cell Biochem; 2019 Dec; 120(12):19274-19289. PubMed ID: 31364210
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.
Chen W; Zhou S; Mao L; Zhang H; Sun D; Zhang J; Li J; Tang JH
Tumour Biol; 2016 Aug; 37(8):10011-9. PubMed ID: 27153853
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro.
Eismann J; Hirschfeld M; Erbes T; Rücker G; Jäger M; Ritter A; Weiss D; Gitsch G; Mayer S
Oncol Rep; 2017 Aug; 38(2):993-1004. PubMed ID: 28627686
[TBL] [Abstract][Full Text] [Related]
11. miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay - A review.
El-Mahdy HA; Elsakka EGE; El-Husseiny AA; Ismail A; Yehia AM; Abdelmaksoud NM; Elshimy RAA; Noshy M; Doghish AS
Pathol Res Pract; 2023 Feb; 242():154316. PubMed ID: 36682282
[TBL] [Abstract][Full Text] [Related]
12. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review.
Elrebehy MA; Al-Saeed S; Gamal S; El-Sayed A; Ahmed AA; Waheed O; Ismail A; El-Mahdy HA; Sallam AM; Doghish AS
Int J Biol Macromol; 2022 Aug; 214():583-600. PubMed ID: 35768045
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
14. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
15. Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways.
Doghish AS; El-Mahdy HA; Ismail A; Hegazy M; Mokhtar MM; Elkhawaga SY; Elkady MA; Yehia AM; Elsakka EGE
Pathol Res Pract; 2023 Mar; 243():154371. PubMed ID: 36791561
[TBL] [Abstract][Full Text] [Related]
16. The role of miRNAs in endometrial cancer.
Vasilatou D; Sioulas VD; Pappa V; Papageorgiou SG; Vlahos NF
Epigenomics; 2015; 7(6):951-9. PubMed ID: 26443384
[TBL] [Abstract][Full Text] [Related]
17. A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay.
Doghish AS; Ismail A; Elrebehy MA; Elbadry AMM; Mahmoud HH; Farouk SM; Serea GAA; Elghany RAA; El-Halwany KK; Alsawah AO; Dewidar HI; El-Mahdy HA
Pathol Res Pract; 2022 Sep; 237():154053. PubMed ID: 35926432
[TBL] [Abstract][Full Text] [Related]
18. The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review.
Sianou A; Galyfos G; Moragianni D; Andromidas P; Kaparos G; Baka S; Kouskouni E
Arch Gynecol Obstet; 2015 Aug; 292(2):271-82. PubMed ID: 25697925
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma.
Li L; Shou H; Wang Q; Liu S
Gene; 2019 Apr; 694():76-82. PubMed ID: 30658067
[TBL] [Abstract][Full Text] [Related]
20. miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses.
El-Mahdy HA; Mohamadin AM; Abulsoud AI; Khidr EG; El-Husseiny AA; Ismail A; Elsakka EGE; Mokhlis HA; El-Husseiny HM; Doghish AS
Pathol Res Pract; 2023 May; 245():154457. PubMed ID: 37058745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
